Monday, 16 December 2013

Infosys shares hit 3-year high, GSK Pharma is a long-term buy & more

To ensure delivery directly to your inbox, Please add etnotifications@indiatimes.com to your address book today.
If you are having trouble viewing this newsletter, please click here.
Dated:16 December,2013
Top Headlines

Infosys hits 3-year high of Rs 3464; BofA-ML pegs it at Rs 4000

Top IT stocks have given solid returns over the last few months. Would it be prudent for investors to exit the sector?


$1 bn bet: GSK Pharma a short-term sell, long-term buy, say experts

The stock is at rich valuations despite low sales and profit growth. The open offer by its parent firm is attractively priced, say experts.


Markets okay with 25 bps hike; but a hawkish RBI may trigger selloff

According to analysts, the RBI's mid quarter review of monetary policy and the US Federal Reserve's meeting is likely to dictate the trend for the markets.


Views on Stocks/Markets
IPO/Global Markets
Rupee / Gold
More 'Market' News
Market Round-up
SENSEX 20659.52 -56.06
NIFTY 6154.70 -13.70
S&P500 1,682.32 10.61
NASDAQ 3,726.90 20.72
USD/INR 62.1750 .00
USD/INR 62.1750 .00
NSE Gainers
Scrip Price(Rs.) %Change
Dalmia Bharat Ltd.
160.55 + 19.99
Nitin Spinners Ltd.
15.45 + 19.77
GlaxoSmithKline Pharmaceu
2,925.60 + 18.92
Sharon Bio-Medicine Ltd.
368.65 + 17.57
Aurobindo Pharma Ltd.
349.05 + 12.60
NSE Losers
Scrip Price(Rs.) %Change
Ujaas Energy Ltd.
11.35 -14.34
Elder Pharmaceuticals Ltd
271.90 -9.09
Techno Electric & Enginee
107.45 -6.16
Somany Ceramics Ltd.
100.10 -6.14
Kingfisher Airlines Ltd.
3.90 -6.02

No comments:

Post a Comment